Cite
HARVARD Citation
Ports, W. et al. (n.d.). A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis. British journal of dermatology. pp. 137-145. [Online].